Monthly Archives: September 2015

Featured Stories
Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

FDA Panel to Reevaluate Essure Birth Control Method

Medical experts will meet on Thursday to take a closer look at problems reported with the birth control implant Essure, including chronic pain, bleeding, headaches, and allergic reactions. On September 24, the Obstetrics and Gynecology Devices Panel of the Medical Devices … Continue reading

Posted in Defective Medical Devices, Essure |

New Study Finds Public May Misunderstand FDA “Breakthrough” Designation for New Drugs

In a newly published article in JAMA Internal Medicine, researchers say the U.S. Food and Drug Administration (FDA) should be cautious in using words like “breakthrough” and “promising” when making announcements about new drugs because the public may not understand … Continue reading

Posted in Pharmaceuticals |

FDA Expands Warnings about Infection Risk from Medical Scopes

Federal regulators have expanded warnings about medical scopes that can spread infections among patients. Contaminated bronchoscopes pose a risk to patients. The Food and Drug Administration (FDA) said it was investigating reports that bronchoscopes are causing infections in patients even … Continue reading

Posted in Defective Medical Devices, Health Concerns |

Eleven Ayurvedic Dietary Supplements Recalled for Excess Lead and Mercury

Butala Emporium, Inc. of Jackson Heights, New York has announced a voluntary recall of 11 Ayurvedic (dietary) supplements that were found to contain elevated lead and mercury levels. These elevated lead and mercury levels may cause health problems, particularly in … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Toxic Substances |

GM Announces Settlement and Deferred Prosecution Agreement in Faulty Ignition Switch Case

Yesterday, General Motors announced a $900 million criminal settlement ending the government’s investigation into faulty ignition switches in the Chevy Cobalt, Saturn Ion and other small GM cars. The settlement resolves more than half of the death and personal injury lawsuits … Continue reading

Posted in Accident, Defective Products, Legal News, Product Recalls, Recalled Vehicles |

200,000 Recaro Car Seats Recalled

Nearly 200,000 car seats made by Recaro Child Safety are being recalled due to safety concerns. WCTI 12 reports that the top tether of the ProRide and the Performance Ride car seats can detach from the seat in the event … Continue reading

Posted in Legal News |

Parker Waichman Lobbied in Congress Yesterday for Permanent Zadroga Act Extension

Parker Waichman was among the many who lobbied Congress to permanently extend the 2010 Zadroga Act and ensure first responders, survivors, and their families receive full benefits under the Act’s two programs. Parker Waichman LLP, a national law firm that … Continue reading

Posted in Accident, Health Concerns, Legal News, Press Releases, Toxic Substances |

Two HeartMate Patients Die When Unable to Switch Power Source Soon Enough

On Monday, Thoratec Corporation sent an Urgent Medical Device Correction Letter to all hospitals with patients supported by the HeartMate II LVAS (left ventricular assist system). Two patients died when they were unable to switch from the devices’ primary controller … Continue reading

Posted in Defective Medical Devices |

FDA Sets for New Prescribing and Monitoring Requirements for Schizophrenia Drug Clozapine

The U.S. Food and Drug Administration (FDA) is making changes to the requirements for prescribing, monitoring, dispensing, and receiving the schizophrenia medicine clozapine, to address safety concerns about a serious blood condition called severe neutropenia. Severe neutropenia is a dangerously … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Jon Stewart Joins Today’s Washington Rally for Permanent Extension of the Zadroga 9/11 Health & Compensation Act

Former “Daily Show” host Jon Stewart will rally today in Washington DC with 9/11 first responders and recovery workers, survivors and their families, physicians, and advocates to lobby Congress for a permanent extension and funding for the James Zadroga 9/11 … Continue reading

Posted in Asbestos, Health Concerns, Toxic Substances, Zadroga Act Claims |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.